Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial

By afschroeder • August 7, 2025

Revaiah PC, Serruys PW, Onuma Y, Andreini D, Budoff MJ, Sharif F, Chernofsky A, Vikarunnessa S, Wiethoff AJ, Yates D, Achouba A. Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening - The VICTORION-PLAQUE primary prevention trial. Am Heart J. 2025 Aug 4:S0002-8703(25)00291-1. doi: 10.1016/j.ahj.2025.08.001. Epub ahead of print. PMID: 40769373.

Tags: Cardiology/Epi, CCTA derived Fractional Flow Reserve (FFR(CT)), coronary computed tomography angiography (CCTA), CT-adapted Leaman score, Harbor UCLA, Inclisiran, Low density Lipoprotein Cholesterol (LDL-C), non-obstructive coronary artery disease (NOCAD), Publications, total atheroma volume (TAV)

Initial Diuretic Strategy During Hospitalization for Heart Failure and Associated Outcomes: Insights from the TREAT-AHF Registry

Varshney AS, Ambrosy AP, Furst A, Zheng J, Bhatt AS, Lala A, Fonarow GC, Fudim M, Greene SJ, Collins SP, Testani JM, Sandhu AT. Initial[...]

Abdominal Wall Erythema as a Suspected Extracardiac Manifestation of Cardiac Allograft Rejection

Sahlool Y, Khoury F, Akhondi A. Abdominal Wall Erythema as a Suspected Extracardiac Manifestation of Cardiac Allograft Rejection. Cureus. 2026 Jul 7;18(7):e112218. doi: 10.7759/cureus.112218. PMID:[...]

Proteomic Mediators of Chronic Obstructive Pulmonary Disease Phenotypes and Coronary Artery Calcification Burden in Ever Smokers

Abbasi A, Ahmad K, Pratte KA, Moore J, DeMeo DL, Manubolu VS, Kinninger A, Tiller NB, Bowler RP, Budoff M, Casaburi R, Rossiter HB. Proteomic[...]